Artificial Intelligence in Pharma - Impact, Trends, Key Players and Top AI Drugs
Summary
This report investigates the impacts and development of Artificial Intelligence within the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot to prioritize them within your sector.
Scope
This report gives important, expert insight you won’t find in any other source. 22 figures throughout the report illustrate major points and trends in future pharmaceutical sales forecasts and company pipelines. This report is required reading for -
Investors that want to understand past trends impacting the biopharmaceutical industry as well as identifying companies to invest in
Companies that are interested in entering the biopharmaceutical space and where best to focus on
Large pharma companies with investment groups or BD teams looking to see which companies lead the industry in the past and how they led
Small and medium pharma who want to focus their drug portfolio on future trends and are looking for partnership opportunities
Reasons to Buy
Insights on key areas of AI focus
Insights on leading AI Champion companies
Insights on leading AI drugs based on their Sales and Forecasts
Therapeutic and Indication insights into the AI biopharmaceutical market